Martin Shkreli Has Taken An Activist Position in AMAG

Martin Shkreli, CIO of MSMB Capital Management, took a 5.8% ownership interest in Amag Pharmaceuticals (AMAG) in a bid to prevent Amag merging with Allos Therapeutics (ALTH).

Keep Reading →